S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
Log in

NASDAQ:ACADACADIA Pharmaceuticals Price Target & Analyst Ratings

$42.87
-0.65 (-1.49 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$42.69
Now: $42.87
$43.93
50-Day Range
$41.57
MA: $49.40
$57.00
52-Week Range
$23.77
Now: $42.87
$58.72
Volume1.19 million shs
Average Volume1.55 million shs
Market Capitalization$6.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.68

Analyst Ratings

ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
15 Wall Street analysts have issued ratings and price targets for ACADIA Pharmaceuticals in the last 12 months. Their average twelve-month price target is $57.33, suggesting that the stock has a possible upside of 33.74%. The high price target for ACAD is $72.00 and the low price target for ACAD is $29.00. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.872.942.942.93
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $57.33$58.50$55.59$52.79
Price Target Upside: 33.74% upside8.96% upside23.01% upside21.54% upside

ACADIA Pharmaceuticals (NASDAQ:ACAD) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/28/2020Canaccord GenuityReiterated RatingHold$29.00Low
7/21/2020Jefferies Financial GroupReiterated RatingBuy$60.00High
7/21/2020CitigroupLower Price Target$69.00 ➝ $63.00High
7/21/2020Cantor FitzgeraldLower Price TargetOverweight$63.00 ➝ $61.00High
7/21/2020OppenheimerLower Price TargetPositive ➝ Market Perform$53.00 ➝ $42.00High
7/21/2020Royal Bank of CanadaLower Price TargetOutperform$61.00 ➝ $55.00High
7/16/2020Needham & Company LLCInitiated CoverageBuy$60.00Low
7/6/2020Stifel NicolausUpgradeHold ➝ Buy$41.00 ➝ $71.00High
5/8/2020JPMorgan Chase & Co.Boost Price TargetOverweight$50.00 ➝ $55.00Medium
3/31/2020Goldman Sachs GroupUpgradeNeutral ➝ Buy$45.00 ➝ $72.00High
3/5/2020CowenReiterated RatingBuy$66.00Medium
2/27/2020HC WainwrightReiterated RatingBuy$60.00High
12/16/2019GuggenheimInitiated CoverageBuy$60.00High
9/13/2019SVB LeerinkUpgradeMarket Perform ➝ Outperform$21.00 ➝ $50.00Low
9/9/2019Piper Jaffray CompaniesBoost Price TargetOverweight$35.00 ➝ $56.00High
7/31/2019Bank of AmericaSet Price TargetBuy$31.00N/A
5/31/2019Raymond JamesBoost Price TargetStrong-Buy$40.00 ➝ $43.00Low
11/16/2018UBS GroupInitiated CoverageNeutral$39.00Low
8/9/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$50.00 ➝ $27.00High
10/2/2017LADENBURG THALM/SH SHReiterated RatingBuy$48.00 ➝ $50.00Low
(Data available from 8/5/2018 forward)
This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.